Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

386 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Aldoxorubicin for the treatment of soft tissue sarcoma.
Sachdev E, Sachdev D, Mita M. Sachdev E, et al. Among authors: mita m. Expert Opin Investig Drugs. 2017 Oct;26(10):1175-1179. doi: 10.1080/13543784.2017.1371134. Epub 2017 Aug 28. Expert Opin Investig Drugs. 2017. PMID: 28846045 Review.
Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas.
Chawla SP, Staddon AP, Baker LH, Schuetze SM, Tolcher AW, D'Amato GZ, Blay JY, Mita MM, Sankhala KK, Berk L, Rivera VM, Clackson T, Loewy JW, Haluska FG, Demetri GD. Chawla SP, et al. Among authors: mita mm. J Clin Oncol. 2012 Jan 1;30(1):78-84. doi: 10.1200/JCO.2011.35.6329. Epub 2011 Nov 7. J Clin Oncol. 2012. PMID: 22067397 Clinical Trial.
Metabolism of patupilone in patients with advanced solid tumor malignancies.
Kelly KR, Zollinger M, Lozac'h F, Tan E, Mita A, Waldmeier F, Urban P, Anand S, Wang Y, Swart P, Takimoto C, Mita M. Kelly KR, et al. Among authors: mita a, mita m. Invest New Drugs. 2013 Jun;31(3):605-15. doi: 10.1007/s10637-012-9838-2. Epub 2012 Jul 18. Invest New Drugs. 2013. PMID: 22918719 Clinical Trial.
386 results